9min chapter

More or Less: Behind the Stats cover image

Vaccine claims, Alzheimer's treatment and Tim's Parkrun times

More or Less: Behind the Stats

CHAPTER

Understanding the Impact of Dannanamab on Alzheimer's Disease

This chapter explores the research findings on the effectiveness of Dannanamab, a new drug for Alzheimer's disease. It discusses the drug's ability to slow down the progression of the disease, alleviate symptoms, and remove amyloid plaques from the brain. The chapter also delves into the debate surrounding the importance of amyloid plaques and explores the concept of minimum clinically important differences in measuring treatment effects.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode